MRVI
Maravai Lifesciences Holdings IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.62B
P/E Ratio
—
EPS
$-0.71
Beta
0.62
52W High
$5.00
52W Low
$1.99
50-Day MA
$3.54
200-Day MA
$3.29
Dividend Yield
—
Profit Margin
-51.10%
Forward P/E
370.37
PEG Ratio
—
About Maravai Lifesciences Holdings Inc
Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines, and to support human disease research in the United States and internationally. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $204.73M |
| Gross Profit (TTM) | $61.67M |
| EBITDA | $-38.02M |
| Operating Margin | 1.09% |
| Return on Equity | -41.00% |
| Return on Assets | -6.59% |
| Revenue/Share (TTM) | $1.41 |
| Book Value | $1.43 |
| Price-to-Book | 3.08 |
| Price-to-Sales (TTM) | 7.93 |
| EV/Revenue | 3.69 |
| EV/EBITDA | 1.77 |
| Quarterly Earnings Growth (YoY) | -32.70% |
| Quarterly Revenue Growth (YoY) | 40.50% |
| Shares Outstanding | $147.51M |
| Float | $102.60M |
| % Insiders | 11.71% |
| % Institutions | 88.42% |
Historical Volatility
HV 10-Day
52.05%
HV 20-Day
88.27%
HV 30-Day
81.35%
HV 60-Day
69.22%
HV Rank
86.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($5.70 target)
5
Buy4
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026